No EU Fast Track for AZ’s Imfinzi In Stage III Lung Cancer

 
• By Maureen Kenny
  
Darts
AstraZeneca missed its target of getting EU speedy review for Infimzi • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer